TrophoSYS
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 3
About TrophoSYS
a. TrophoSYS is a biotechnology company that focuses on advancing technologies that optimize breeding processes while adhering to environmental and ethical considerations. TrophoSYS focuses on two key areas: separating live and dead cells in ejaculates to improve breeding results, and separating X and Y chromosome-containing sperm for targeted livestock rearing. These technologies enable efficient and ethical livestock management, reducing the environmental impact and enhancing animal welfare.
Who invested in TrophoSYS
3 investors across 2 rounds
See all investors in TrophoSYS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TrophoSYS
Who invested in TrophoSYS?
TrophoSYS has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TrophoSYS raised?
TrophoSYS has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TrophoSYS last raise money?
TrophoSYS's most recent round on record is a Series A, in Jan 2022.
What does TrophoSYS do?
TrophoSYS is a biotechnology company.
Where is TrophoSYS headquartered?
TrophoSYS is headquartered in Jena, Germany.
Which VCs invest in companies like TrophoSYS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at TrophoSYS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TrophoSYS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.